News
Lunai Bioworks
LNAI · NASDAQ
$0.515+$0.043 (+9.11%)TodayMarket closed ·
Prev close $0.472
Latest news
- NewsAvi Kapoor
Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
- NewsRishabh Mishra
Stock Market: Will S&P 500 Open Up or Down Today?
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- Press releasePRNewswire
Lunai Bioworks (NASDAQ: LNAI) Expands Parkinson's Platform Through Exclusive Tanaist Agreement
- Press releasePRNewswire
Lunai Bioworks (Nasdaq: LNAI) Demonstrates AI Chemical-Risk Screening for Generative AI
- Press releasePRNewswire
Lunai Bioworks (NASDAQ: LNAI) Issues Correction to Press Release Regarding Second Amended Complaint
- News
Lunai Bioworks Files Second Amended Complaint Against Six Registered Broker-Dealers And Two Broker-Dealer Principals As Defendants In U.S. District Court, Delaware
- Press releasePRNewswire
Lunai Bioworks (Nasdaq: LNAI) Names Six Broker-Dealers in Expanded Naked Short Selling Suit
- News
Lunai Bioworks Signs Master Collaboration Agreement With BrainStorm Therapeutics; BioSymetrics Publishes Parkinson's Disease AI White Paper, Initial Data Expected In 1H 2027
- Press releasePRNewswire
Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027
- Press releasePRNewswire
Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit
- Press releasePRNewswire
LUNAI BIOWORKS: CEO LETTER TO SHAREHOLDERS
- NewsMohd Haider
Lunai Bioworks (LNAI) Stock Is Trending Overnight — Here's Why It Spiked Nearly 81% In After-Hours Session
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Press releasePRNewswire
Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration
- Press releasePRNewswire
Federal Judge Orders Expedited Discovery to Identify 'John Doe' Defendants 'Naked' Short-Sellers of Lunai Common Stock
- Press releasePRNewswire
LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT
- Press releaseGlobe Newswire
CNS Drug Delivery Technologies Are Reshaping Alzheimer's and Biodefense Research
- Press releaseGlobe Newswire
Dickinson Wright and Fox Rothschild Join Forces to File Lawsuit Against 'John Doe' 'Naked' Short-Sellers of Lunai Common Stock
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- Press releasePRNewswire
Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP
- News
Stock Market Today: Nasdaq, S&P 500 Futures Gain While Dow Slips Amid Israel-Lebanon Ceasefire Extension—Intel, SAP, Lunai Bioworks In Focus (UPDATED)
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releasePRNewswire
Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships
- Press releasePRNewswire
Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- Press releasePRNewswire
Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- Press releasePRNewswire
Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- NewsAvi Kapoor
Nasdaq Surges Over 100 Points; Academy Sports And Outdoors Posts Downbeat Earnings
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.